Bioengineered T-cell therapies for precision immunotherapy in renal transplantation, autoimmune relapse, and sensitization.

Muhammad A, Huang H, Tang R, Zhang Y, Xiao Y, Yuan Q, Xiao X

Open source

DOI
10.1093/ckj/sfaf248
Published
2025 Sep
Container
Clinical kidney journal
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ckj/sfaf248,
  title = {Bioengineered T-cell therapies for precision immunotherapy in renal transplantation, autoimmune relapse, and sensitization.},
  author = {Muhammad A and Huang H and Tang R and Zhang Y and Xiao Y and Yuan Q and Xiao X},
  year = {2025},
  journal = {Clinical kidney journal},
  doi = {10.1093/ckj/sfaf248},
  url = {https://doi.org/10.1093/ckj/sfaf248}
}

RIS

TY  - JOUR
TI  - Bioengineered T-cell therapies for precision immunotherapy in renal transplantation, autoimmune relapse, and sensitization.
AU  - Muhammad A
AU  - Huang H
AU  - Tang R
AU  - Zhang Y
AU  - Xiao Y
AU  - Yuan Q
AU  - Xiao X
PY  - 2025
JO  - Clinical kidney journal
DO  - 10.1093/ckj/sfaf248
UR  - https://doi.org/10.1093/ckj/sfaf248
ER  - 

APA

A, M., H, H., R, T., Y, Z., Y, X., Q, Y., & X, X. (2025). Bioengineered T-cell therapies for precision immunotherapy in renal transplantation, autoimmune relapse, and sensitization.. Clinical kidney journal. https://doi.org/10.1093/ckj/sfaf248

Source records